Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
10.
Rev Med Chir Soc Med Nat Iasi ; 86(1): 57-61, 1982.
Artículo en Rumano | MEDLINE | ID: mdl-25591251

RESUMEN

Out of 205 children, former patients with viral hepatitis, investigated after the end of the follow-up period by clinical and laboratory examinations, 9 (4.4%) presented mild or moderate pathological alterations. At the second control, carried out after an another interval de 1-1½ years, the pathological alterations were refound only in 2 of the former patients, suggesting that all the others presented lasting forms of acute viral hepatitis evolving towards healing. The presence of AgHBs and the alteration of proteinogramme in the acute phase of VH can serve as criteria of unfavourable prognosis of the disease evolution and impose a preferential follow-up of this category of patients.


Asunto(s)
Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Antígenos e de la Hepatitis B/sangre , Hepatitis B Crónica/diagnóstico , Hepatitis B Crónica/virología , Adolescente , Biomarcadores/sangre , Niño , Preescolar , Femenino , Estudios de Seguimiento , Hepatitis B/complicaciones , Hepatitis B Crónica/sangre , Hepatomegalia/virología , Humanos , Lactante , Masculino , Índice de Severidad de la Enfermedad , Esplenomegalia/virología
12.
Artículo en Rumano | MEDLINE | ID: mdl-141081

RESUMEN

A group of 39 former dysentery patients, who continued to excrete Shigella bacteria after a first cure of antibiotics when full clinical recovery was obtained, were treated differentially under bacteriological control. The carrier state was still extent in 7% of the cases after three antibiotic or chemotherapeutical cures. No direct relation was found between the sensitivity of Shigella to chemotherapeutics and the level of the carrier state. Although treated already in the acute stage with adequate antibiotics, resistance to a second therapeutical attempt was recorded in a proportion of 33%. It is considered useless to repeat the antibiotic or chemotherapeutical cures in the treatment of convalescent carriers because of the low efficiency and the biological and economical disadvantages.


Asunto(s)
Antibacterianos/uso terapéutico , Disentería Bacilar/tratamiento farmacológico , Adolescente , Adulto , Antibacterianos/administración & dosificación , Portador Sano/tratamiento farmacológico , Niño , Preescolar , Convalecencia , Análisis Costo-Beneficio , Humanos , Lactante , Persona de Mediana Edad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...